Biopharma Co. Sues Over Cancer Drug Clinical Trial Mix-Up

Law360, New York (September 26, 2012, 2:40 PM EDT) -- Peregrine Pharmaceuticals Inc. on Monday sued a clinical testing company in California federal court, alleging it mixed up the results of a clinical trial for a new cancer treatment, causing Peregrine to have to rescind its promising trial results.

According to the Tustin, Calif.-based biopharmaceutical company’s complaint, Fargo, N.D.-based Clinical Supplies Management Inc. ran one of three randomized, double-blind, placebo-controlled Phase II trials for the drug bavituximab as part of a testing services agreement with Peregrine. Bavituximab, a first-of-its-kind monoclonal antibody treatment that prompts the immune system...
To view the full article, register now.




Case Information

Case Title

Peregrine Pharmaceuticals Inc v. Clinical Supplies Management Inc

Case Number



California Central

Nature of Suit

Contract: Other


Jesus G. Bernal

Date Filed

September 24, 2012

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.